LURASIDONE HYDROCHLORIDE (lurasidone hydrochloride) by Agepha Pharma is 12. Approved for schizophrenia, depression, schizophrenia. First approved in 2019.
Drug data last refreshed 1w ago
12.1 Mechanism of Action The mechanism of action of lurasidone in the treatment of schizophrenia and bipolar depression is unclear. However, its efficacy in schizophrenia and bipolar depression could be mediated through a combination of central dopamine D 2 and serotonin Type 2 (5HT 2A ) receptor…
Worked on LURASIDONE HYDROCHLORIDE at Agepha Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.